论文部分内容阅读
Ｇａｒｖａｎ研究所开发糖尿病新药悉尼的Ｇａｒｖａｎ研究所将对一种新的化合物展开研究。据称，这种化合物能够在不增加胰岛素水平的情况下降低人体对胰岛素的耐受性。该化合物是由ＳｍｉｔｈｋｌｉｎｅＢｅｅｃｈａｍ合成的，代号为ＢＲＬ４９６５３。人们期望它能改善...
Garvan Institute to Develop New Drugs for Diabetes The Garvan Institute in Sydney will study a new compound. Allegedly, this compound can reduce the body’s insulin resistance without increasing the level of insulin. The compound was synthesized by Smithkline Beecham, codenamed BRL49653. People expect it to improve ...